News
Real-world data support safety of newer LAA device
More than 18 months after approval, the Watchman FLX left atrial appendage closure device is performing well at 45 days in real-world use.
News
Irregular and long periods linked to NAFLD
When compared with regular menstrual cycles, irregular cycles were associated with nonalcoholic fatty liver disease in a study, but experts are...
News
New data explore risk of magnetic interference with implantable devices
Portable electronics embedded with magnets powerful enough to impair CV device functions are proliferating.
News
Guselkumab controls axial involvement in PsA through 2 years
In psoriatic arthritis patients with axial involvement, researchers saw sustained improvement with guselkumab through 100 weeks on all outcomes...
News
Boxed warning for JAK inhibitors belies their durability in real-world registry studies
JAK inhibitors’ discontinuation and retention rates were similar to those for other biologic disease-modifying antirheumatic drugs, including...
News
Real-world data reinforce stem cell transplant for progressive systemic sclerosis
In real-world study, stem cell transplant provides major advantages for rapidly progressive systemic sclerosis if strict selection criteria are...
News
Absolute increase in Kawasaki CV risk remains small in long-term follow-up
Relative to controls, the increased long-term cardiovascular risk of patients with Kawasaki disease is small in most patients.
News
Delays in NSTEMI hospitalization linked to lower survival
After onset of non-STEMI symptoms, delays in hospitalization are linked to poorer long-term outcomes.
News
Daily aspirin linked to increased risk of heart failure
Daily aspirin may need to be reconsidered in those at risk of heart failure, based on evidence of an association.
News
Ticagrelor reversal agent achieves quick hemostasis: REVERSE-IT
The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a...
News
DREAM-HF: Negative stem cell trial in heart failure may still offer promise
Despite zero evidence of benefit on the primary endpoint, stem cell transplant is still promising in heart failure.
News
EHRs have no impact on inpatient heart failure clinical choices or outcomes
Relative to usual care, prognostic information at the bedside provided no advantage for heart failure care.
News
No advantage shown for LAA ligation as adjunct to pulmonary vein isolation
For AFib control, left atrial appendage ligation is not additive to pulmonary vein ventral isolation at 12 months.
News
BP Track: Blood pressure control rates dropped during pandemic
Data culled from 24 health systems showed lower rates of blood pressure control during the COVID-19 pandemic.
News
Direct comparison shows differing strengths for left atrial closure devices
For left atrial appendage closure, differences are found between the Amplatzer Amulet and the Watchman FLX in randomized trials.